PSYC's CEO Highlights Growth of Psychedelic Spotlight in 2021 Year-End Review
December 14 2021 - 8:30AM
InvestorsHub NewsWire
PSYC’s CEO Highlights Growth of Psychedelic Spotlight
in 2021 Year-End
Review
PSYC CEO, David
Flores, Reflects on the Success of Psychedelic Spotlight and the
Road Ahead for PSYC
LAKE OSWEGO, OR
-- December 14, 202 -- InvestorsHub NewsWire
-- Global Trac Solutions,
Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) a media leader for the
emerging sector of medicinal psychedelics, and brain trust behind
Psychedelic Spotlight, a top ranking psychedelic news and
information platform, are proud to provide their valued
shareholders with a 2021 year-end review from the Company’s CEO,
David Flores, to highlight some of PSYC’s key achievements
throughout 2021 along with his opinion on the Company’s positioning
heading into 2022.
Statement from PSYC CEO, David
Flores
Dear
Shareholders,
Thanking you all
for your continued support, loyalty, and belief in
PSYC.
2021 began with
very clear and targeted goals of establishing Psychedelic
Spotlight as a tangible asset for the Company. We recognized
that any monetization aspirations will be heavily reliant on our
ability to grow into a prominent media platform for the medicinal
psychedelic industry.
Setting this
objective into motion, we first began meticulously crafting a
variety of SEO optimization strategies to integrate into the
content we produce and publish for Psychedelic Spotlight. As the
year progressed, these strategies slowly started yielding exciting
results in the form of increased website traffic and page views, as
well as more favorable rankings on Google under the search term
“psychedelic news.”
Secondly, our
strategy focused on producing industry leading content that
expanding audiences within the medicinal psychedelic sector find
every bit as engaging and entertaining as they do informative. By
tapping into the creative talents of Matthew Dunehoo, Video
Producer and Director for Psychedelic Spotlight, and Greg Gilman,
Copy Chief for Psychedelic Spotlight, we succeeded in producing
grade A content both in digital and written form that effectively
resonates with a society more excited than ever before about the
healing potential of
psychedelics.
Psychedelic
Spotlight’s success in 2021 can be quantified by our site’s
growing achievements of consistently realizing over 500K page
views each month and its number one ranking on Google for
psychedelic news. These milestone achievements prove that our
evolution into the most prominent media platform in the industry is
ripe and ready for
monetization.
Establishing a
sizable audience and building a recognizable brand identity for
Psychedelic Spotlight is precisely what we identified as the first
challenge in need of tackling prior to launching any sustainable
monetization efforts.
It’s therefore
imperative not to gloss over the significance and dynamic value of
conquering this challenge and the credit due to our amazing team,
which continually demonstrates an inspiring level of
commitment.
Monetizing
Psychedelic
Spotlight
PSYC Media
Services officially launched in early Q4 of 2021.
Our latest platform offers a unique suite of industry-tailored
marketing, advertising, and public relations-style services for the
growing list of companies operating within the medicinal
psychedelic sector.
By combining
Psychedelic Spotlight’s established presence and brand recognition
with the expert level content production of our team, part of PSYC
Media Services’ value will be delivering tangible results to the
companies and brands with whom we
work.
Moreover,
ongoing growth and expansion of the medicinal psychedelic industry
in the coming years indicates tremendous potential to create
several revenue streams for the Company through PSYC Media
Services.
Swati Sharma,
Media Director for Psychedelic Spotlight, currently oversees
and manages this specific platform and played an integral role
alongside Sarah Abelsohn, Director of Psychedelic Spotlight, in
recent months developing the framework for PSYC Media Services. We
further intend to add an incredibly talented Sales & Marketing
Executive to build a dedicated team and maximize the
value of PSYC Media Services throughout
2022.
We are committed
to maintaining a dynamic, strategic approach to revenue
optimization by identifying all opportunities to monetize
Psychedelic Spotlight, integrate vertically and horizontally,
create scale, and remain focused on further solidifying our
position as medicinal psychedelics’ most prominent,
trusted media
platform.
PSYC Investments
and Partnerships
The Conscious
Fund (“TCF”)
In January 2021,
we completed an investment in the amount of $125,000 USD in TCF I
LP (a/k/a “The Conscious Fund”) by way of a Private Placement
Memorandum. We remain incredibly bullish on both the growth
and value proposition this investment can yield over the next few
years.
Throughout 2021,
several companies within TCF’s portfolio of psychedelic-focused
companies made significant strides in executing their respective
fundamental strategies and unlocking long term growth
potential.
Notable
highlights include Cybin becoming
the first psychedelic company to list on the NYSE, in addition to
their progress with four ongoing drug programs. Wesana Health, led
by CEO Daniel Carcillo, two-time Stanley Cup champion, and backed
by retired boxing heavyweight champion Mike Tyson, achieved an
up-listing to the OTCQB. Enveric
Biosciences acquired MagicMed
Industries in May and currently lists on the NASDAQ.
Finally, April 19
Discovery is
operationally profitable and received considerable recognition for
its discovery of 17 new psychedelic
compounds.
PsycheDev
Inc.
In January 2021,
we completed an investment into PsycheDev Inc, a digital mental
health and wellness company. Our investment entitled PSYC to a 15%
equity stake in PsycheDev, who’s primary concept was focused on
developing and launching an application utilizing mindful resources
to achieve peak performance and an optimal state of mental
wellbeing.
As of the date
of this press release, PSYC remains invested in this concept. In
the coming weeks, however, we expect to share some important and,
in my opinion, exciting updates related to a revision in the
structure of this investment and the value potential we believe it
may present the Company with over the course of 2022 and
beyond.
Microdose
Psychedelic Insights
(“Microdose”)
We continue to
collaborate with Microdose occasionally to provide promotional
support for the various conferences they continue to host. Serving
as a media partner for Microdose’s Wonderland Miami conference in
November went down as one of the largest psychedelic business
conferences held
to-date.
The Psychedelic
Investor
In October 2021,
we began a media partnership with The Psychedelic Investor, a
notable media platform within the psychedelic sector offering
unique insight and perspective related to ongoing developments
throughout the
industry.
This
instrumental partnership is expediting Psychedelic Spotlight’s
audience expansion and reach while enhancing our ability to share
more business-focused content across our platform. Increased public
market attention to and interest in psychedelics may help to
maximize this partnership’s potential in 2022 and establish
Psychedelic Spotlight as the most valuable resource for growing
business communities of medicinal
psychedelics.
Community
Outreach
We remain
committed to constantly identifying opportunities to give back
to the community.
This year, PSYC
proudly became one of the very first corporate sponsors of Fireside
Project and their psychedelic Peer Support Line, which offers free,
confidential peer support by phone and text message to people in
the midst of psychedelic experiences, people holding space for
others who are in the midst of psychedelic experiences, and people
integrating past psychedelic
experiences.
As we grow as a
company and achieve the success we believe we are capable of
achieving, our goals are to expand on our ability to give back and
lead a team with social responsibility not only for the
shareholders and stakeholders of PSYC, but for our community, our
industry, and our
planet.
The Road
Ahead
Despite the
aforementioned accomplishments and milestones achieved throughout
2021, there remains a great deal of work ahead. Corporate
structure, leadership, and governance are areas of high priority
for the Company heading into 2022, in addition to building a
dynamic Sales and Marketing team.
By establishing
Psychedelic Spotlight as a tangible asset for PSYC, I believe we
are strategically positioned for additional growth
opportunities in an industry with the potential to completely
disrupt and revolutionize our world of mental health and mental
health-related treatments. Thanks to Psychedelic Spotlight, PSYC is
now the voice of this industry
and movement.
Since stepping into
the CEO role in July 2020, I determined that everything we do at
PSYC would become part of a meticulous process, not to be rushed.
It is clear, to achieve sustainable growth, we cannot afford to
skip any steps along the way. While the progress made over the past
18 months may appear small relative to the challenges ahead, I
believe these crucial strides have laid the groundwork for a
successful path forward.
We
fully acknowledge and understand the immense challenges
still ahead. As we transition to 2022, active steps are underway to
expand and shore up the Company’s executive team to dedicate
more time and resources towards our goal of up-listing to the
OTCQB, addressing the debt on our books, raising additional capital
necessary to foster future growth, and creating an independent
Board of Directors.
However, despite these
challenges, as well as the volatility our stock is currently
experiencing, we at PSYC are more excited and motivated than ever
before for the future. Our long-term vision and dedication, the
potential presence within the medicinal psychedelic industry, and
the opportunities which we are surrounded by should help drive the
success of PSYC over the next several
months.
From a small,
relatively unknown website a year ago, to now one of the most
prominent media hubs for the psychedelic movement, our hope is that
you recognize the value in trusting the big picture process of
meeting daunting challenges despite uncertain economic
landscapes.
It won’t be quick. It
won’t be easy. But I intend to make 2022 the start of a process by
which we create and grow revenue streams, reorganize capital
structures, enhance corporate governance, increase public awareness
of our stock, and continue to build PSYC into the dominant,
most successful publicly traded media company within the medicinal
psychedelic industry.
Through these careful
measures, my goal is for the Company to return maximum value to
you, our loyal shareholders. Thank you again for your support.
Here's to a safe, healthy, and prosperous new
year.
Sincerely,
David Flores, CEO Global Trac Solutions, Inc.
& Psychedelic Spotlight
About Global Trac Solutions, Inc.
(OTCPink: PSYC)
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, we believe investors are speculating that the
psychedelic boom could be bigger than that of cannabis. PSYC is
your source for current investment related news specific to
psychedelic medicines and cutting-edge research improving overall
health, moving this sector into the mainstream.
We are dedicated to a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the future. We contend that
we are truly the right TRAC to follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, that
may cause our results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by the forward-looking statements in this
press release. This press release should be considered in light of
all filings of the Company that are disclosed on the OTC
Markets.com website.
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
responsibly.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024